<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03628846</url>
  </required_header>
  <id_info>
    <org_study_id>1706176501</org_study_id>
    <nct_id>NCT03628846</nct_id>
  </id_info>
  <brief_title>Opioid Use After Traumatic Injury in Adolescents</brief_title>
  <official_title>A Prospective Survey of Opioid Use After Traumatic Injury in Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, 1 in 8 adolescents continue to receive prescription opioids a year or more after
      injury. By longitudinally surveying patients, we can identify risk factors and pathways to
      nonmedical opioid use. Furthermore, by assessing whether pain management and mental health
      treatment after injury moderates sustained opioid use and prescription opioid misuse, we can
      create targeted interventions to reduce future nonmedical opioid use in adolescents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective cohort study that will follow participants for 2 years and administer
      surveys to adolescents both traumatically injured and uninjured on prescription opioid usage,
      substance use, utilization of pain management and mental health services, and mental and
      physical health condition conditions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prospectively determine drivers of sustained opioid use and prescription opioid misuse.</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identify patient-reported factors for sustained prescription opioid use, including chronic pain and mental health conditions such as PTSD, depression, anxiety, and sleep disorders.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess behavioral, social, and clinical predictors of prescription opioid misuse and nonmedical opioid use by longitudinally surveying injured adolescents.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualitatively determine patients' motives for continued opioid therapy, prescription opioid misuse, and nonmedical opioid use by interviewing injured adolescents.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analyze genetic information, obtained via saliva sample and the company 23andMe, from each participant to determine if some people are more likely to use more pain medication than others or respond better to certain pain medications.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Opioid Use</condition>
  <condition>Traumatic Injury</condition>
  <condition>Adolescent Behavior</condition>
  <condition>Substance Abuse Disorder</condition>
  <arm_group>
    <arm_group_label>Traumatically Injured Adolescent</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Not Traumatically Injured Adolescent</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva will be collected at baseline only for the purpose of analyzing genetic data on each
      participant.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Traumatically injured patients admitted to either Eskenazi Hospital or Riley Hospital,
        between the ages of 12 and 20.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is 12-20 years of age

          -  Adolescent admitted for trauma OR adolescent with no recent trauma

          -  English speaking

          -  Consent can be obtained from a parent or guardian

        Exclusion Criteria:

        - Patients with severe brain injuries or other injuries that prevent survey participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>20 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jodi Raymond, MPH, CSTR, CAISS</last_name>
    <phone>3179445434</phone>
    <email>jraymond3@iuhealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ashley Vetor, MPH, CCRP</last_name>
    <phone>3172747493</phone>
    <email>abozell@iu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa M Bell, PhD</last_name>
      <phone>317-274-7435</phone>
      <email>terebell@iupui.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>August 9, 2018</study_first_submitted>
  <study_first_submitted_qc>August 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Teresa Maria Bell</investigator_full_name>
    <investigator_title>Assistant Professor of Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

